GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

NeuroOne Medical Technologies NMTC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.89

+0.71%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$12.1m

FY2020FY2025

Net income

−$3.6m

FY2020FY2025

Free cash flow

−$2.9m

FY2020FY2025

Shareholders' equity

$7.1m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Revenue$12.1m$3.5m$2.0m$171,169$178,146$1.9m
Research and development$5.0m$5.1m$6.9m$4.9m$3.9m$2.1m
Operating income−$4.2m−$12.1m−$12.0m−$10.0m−$9.9m−$4.9m
Net income−$3.6m−$12.3m−$11.9m−$10.0m−$9.9m−$13.6m
Diluted earnings per share-0.43-2.39-2.97-3.70-3.87-10.65

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assets$10.8m$5.4m$8.1m$12.8m$7.9m$4.8m
Cash and short-term investments$6.6m$1.5m$5.3m$11.1m$6.9m$4.0m
Total liabilities$3.7m$4.5m$1.8m$3.2m$1.4m$2.7m
Debt$266,806$260,160$184,400$202,895$315,673$1.3m
Shareholders' equity$7.1m$822,013$6.2m$9.6m$6.6m$2.1m
Shares outstanding8m5m4m3m3m1m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−$2.8m−$11.0m−$12.9m−$7.5m−$8.6m−$3.4m
Capital spending−$81,742−$120,197−$384,117−$275,226−$67,079−$122,427
Free cash flow−$2.9m−$11.1m−$13.3m−$7.8m−$8.7m−$3.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue313.5%44.4%162.7%
Operating income-25.0%-2.9%61.1%
Net income-28.8%-23.4%58.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-104.9%-216.5%-268.6%—
Net margin-102.4%-213.8%-310.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-10.6-1.1-1.8-1.1-0.9-0.8-1.4-2.3
Price to sales3.14.110.762.949.35.5——

Share price return

Finished calendar years

20252024202320222021202020192018
Return75%-47%-37%92%-33%-57%-47%18%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 6-to-1 reverse split · 16 Apr 2026
  • 3-to-1 reverse split · 1 Apr 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.